Skip to main content

Advertisement

SpringerLink
Log in

An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: Sign of a possible new chapter in headache medicine

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Doenicke A, Brand J, Perrin VL: Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988, 1(8598):1309–1311.

    Article  PubMed  CAS  Google Scholar 

  2. Ferrari MD, Rn KI, Lipton RB, Goadsby PJ: Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001, 358:1668–1675.

    Article  PubMed  CAS  Google Scholar 

  3. Garza I, Swanson JW: Answers to frequently asked questions about migraine. Mayo Clin Proc 2006, 81:1387–1391; quiz 1392.

    Article  PubMed  CAS  Google Scholar 

  4. Goadsby PJ, Lipton RB, Ferrari MD: Migraine—current understanding and treatment. N Engl J Med 2002, 346:257–270.

    Article  PubMed  CAS  Google Scholar 

  5. Goadsby PJ, Edvinsson L, Ekman R: Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988, 23:193–196.

    Article  PubMed  CAS  Google Scholar 

  6. Zagami AS, Goadsby PJ, Edvinsson L: Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990, 16:69–75.

    Article  PubMed  CAS  Google Scholar 

  7. Lassen LH, Haderslev PA, Jacobsen VB, et al.: CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54–61.

    Article  PubMed  CAS  Google Scholar 

  8. Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48–56.

    Article  PubMed  CAS  Google Scholar 

  9. Olesen J, Diener HC, Husstedt IW, et al.: Calcitonin generelated peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004, 350:1104–1110.

    Article  PubMed  CAS  Google Scholar 

  10. Petersen KA, Birk S, Lassen LH, et al.: The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2005, 25:139–147.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ivan Garza
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garza, I. An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: Sign of a possible new chapter in headache medicine. Curr Neurol Neurosci Rep 9, 91–93 (2009). https://doi.org/10.1007/s11910-009-0014-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0014-9

Keywords

Search

Navigation